Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH2 | P05091 | 1/20 | 1.00 |
| ▸ | NPC1 | O15118 | 7/20 | 0.90 |
| ▸ | RAB9A | P51151 | 7/20 | 0.90 |
| ▸ | SMN1; SMN2 | Q16637 | 7/20 | 0.90 |
| ▸ | MEN1 | O00255 | 6/20 | 0.90 |
| ▸ | KMT2A | Q03164 | 6/20 | 0.90 |
| ▸ | CYP2C9 | P11712 | 4/20 | 0.90 |
| ▸ | CYP2C19 | P33261 | 4/20 | 0.90 |
| ▸ | NFKB1 | P19838 | 3/20 | 0.90 |
| ▸ | NFKB2 | Q00653 | 3/20 | 0.90 |
| ▸ | RELA | Q04206 | 3/20 | 0.90 |
| ▸ | CYP2D6 | P10635 | 3/20 | 0.90 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.90 |
| ▸ | TP53 | P04637 | 6/20 | 0.79 |
| ▸ | MAPT | P10636 | 6/20 | 0.79 |
| ▸ | HPGD | P15428 | 6/20 | 0.79 |
| ▸ | ALDH1A1 | P00352 | 6/20 | 0.79 |
| ▸ | CYP3A4 | P08684 | 6/20 | 0.79 |
| ▸ | KDM4E | B2RXH2 | 5/20 | 0.79 |
| ▸ | HSD17B10 | Q99714 | 5/20 | 0.79 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Prunetin SCHEMBL73420 | 1.00 | ALDH2 (1.00) | ALDH2NPC1RAB9ASMN1; SMN2MEN1 | |
| 4',7-Dimethoxy-5-Hydroxygenistein SCHEMBL572108 | 0.95 | RAB9A (1.00) | ALDH2NPC1RAB9ASMN1; SMN2MEN1 | |
| 5-Hydroxy-7-Methoxyisoflavone SCHEMBL6142401 | 0.91 | RAB9A (0.83) | ALDH2NPC1RAB9ASMN1; SMN2MEN1 | |
| SCHEMBL28788159 | 0.90 | KDM4E (0.83) | ALDH2NPC1RAB9ASMN1; SMN2MEN1 | |
| SCHEMBL16226987 | 0.90 | ALDH2 (0.81) | ALDH2NPC1RAB9ASMN1; SMN2MEN1 | |
| SCHEMBL2313317 | 0.90 | NPC1 (0.81) | ALDH2NPC1RAB9ASMN1; SMN2MEN1 | |
| Biochanin SCHEMBL29410271 | 0.88 | RAB9A (1.00) | ALDH2NPC1RAB9ASMN1; SMN2MEN1 | |
| Biochanin SCHEMBL61258 | 0.88 | RAB9A (1.00) | ALDH2NPC1RAB9ASMN1; SMN2MEN1 | |
| Genistein SCHEMBL18241115 | 0.88 | MEN1 (0.89) | ALDH2NPC1RAB9ASMN1; SMN2MEN1 | |
| SCHEMBL2751306 | 0.87 | NPC1 (0.77) | ALDH2NPC1RAB9ASMN1; SMN2MEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 15 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2603098-B1 | METHOD OF IMPROVING STABILITY OF SWEET ENHANCER AND COMPOSITION CONTAINING STABILIZED SWEET ENHANCER | FIRMENICH INCORPORATED (US) | 2025-08-06 | — | — | EP | claimed |
| US-20250161201-A1 | COSMETIC COMPOSITION | THE BOOTS COMPANY PLC (GB) | 2025-05-22 | — | — | US | claimed |
| EP-4479145-A1 | COSMETIC COMPOSITION COMPRISING EXTRACT OF OPHIOPOGON JAPONICUS AND AT LEAST ONE CERAMIDE | The Boots Company PLC (GB) | 2024-12-25 | — | — | EP | claimed |
| WO-2023156069-A1 | COSMETIC COMPOSITION COMPRISING EXTRACT OF OPHIOPOGON JAPONICUS AND AT LEAST ONE CERAMIDE | THE BOOTS COMPANY PLC (GB) | 2023-08-24 | — | — | WO | claimed |
| WO-2023064318-A1 | BIPHASIC COMPOSITIONS COMPRISING ONE OR BOTH OF CARBONATE AND PHOSPHATE | Natural Extraction Systems, LLC (US) | 2023-04-20 | — | — | WO | claimed |
| WO-2022182527-A1 | COMPOSITIONS AND METHODS RELATED TO PHARMACEUTICAL EXCIPIENTS | Natural Extraction Systems, LLC (US) | 2022-09-01 | — | — | WO | claimed |
| US-20250161201-A1 | COSMETIC COMPOSITION | THE BOOTS COMPANY PLC (GB) | 2025-05-22 | — | — | US | disclosed |
| US-20250161200-A1 | COSMETIC COMPOSITION COMPRISING EXTRACT OF OPHIOPOGON JAPONICUS AND AT LEAST ONE CERAMIDE | THE BOOTS COMPANY PLC (GB) | 2025-05-22 | — | — | US | disclosed |
| EP-4479145-A1 | COSMETIC COMPOSITION COMPRISING EXTRACT OF OPHIOPOGON JAPONICUS AND AT LEAST ONE CERAMIDE | The Boots Company PLC (GB) | 2024-12-25 | — | — | EP | disclosed |
| WO-2024189607-A1 | METHODS AND BIOAVAILABLE HIGHLY PERMEABLE COMPOUNDS FOR DISEASES TREATMENT | DIDENKO KIRILL (MX) | 2024-09-19 | — | — | WO | disclosed |
| EP-4259316-A2 | POLYMERIC MEMBRANE | 3M Innovative Properties Company (US) | 2023-10-18 | — | — | EP | disclosed |
| WO-2023156069-A1 | COSMETIC COMPOSITION COMPRISING EXTRACT OF OPHIOPOGON JAPONICUS AND AT LEAST ONE CERAMIDE | THE BOOTS COMPANY PLC (GB) | 2023-08-24 | — | — | WO | disclosed |
| CN-116635135-A | Polymer film | 3M创新有限公司 | 2023-08-22 | — | — | CN | disclosed |
| WO-2023064318-A1 | BIPHASIC COMPOSITIONS COMPRISING ONE OR BOTH OF CARBONATE AND PHOSPHATE | Natural Extraction Systems, LLC (US) | 2023-04-20 | — | — | WO | disclosed |
| WO-2022123428-A2 | POLYMERIC MEMBRANE | 3M INNOVATIVE PROPERTIES COMPANY (US) | 2022-06-16 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250161200-A1 | COSMETIC COMPOSITION COMPRISING EXTRACT OF OPHIOPOGON JAPONICUS AND AT LEAST ONE CERAMIDE | SGMS2, SGMS1, CERS2 | ALDH2 1528/4885NPC1 435/4885RAB9A 2457/4885 |
| US-20250161201-A1 | COSMETIC COMPOSITION | CYP19A1, SHBG, HSD17B11 | ALDH2 1993/4885NPC1 2375/4885RAB9A 4212/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.